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The genetic changes responsible for the attenuation of infectious bursal disease virus (IBDV) have not been defined at
the molecular level, although passage of the virus in cell culture results in the loss of virulence. To understand the molecular
basis of IBDV virulence and attenuation, the IBDV genome segment encoding the precursor polyprotein (NH2-VP2-VP4-VP3-
COOH) of a cell culture-adapted OKYMT strain derived from highly virulent OKYM was cloned as cDNA, and the nucleotide
sequence was determined. Comparison of the identified nucleotide and deduced amino acid sequences of the attenuated
strain with the parental virulent OKYM strain revealed only five amino acid differences: four in the VP2 variable domain and
one in the VP3. Two amino acid substitutions at positions 279 (Asp r Asn) and 284 (Ala r Thr) in the VP2 variable
domain were commonly predicted in another cell culture-adapted strain. These two amino acid changes resulted in reduced
hydrophilia of this region and deletion of the a-helix which might alter the conformation of the virion surface structures.
These results may imply that the amino acid residues at position 279 and 284 in VP2 variable domain contribute to virulence
of IBDV. q 1996 Academic Press, Inc.
The infectious bursal disease virus (IBDV) is the etio- processed into mature VP2 (37 to 40 kDa), VP3 (32 to
logical agent of an immunosuppressive disease of 35 kDa), and VP4 (24 kDa) (13, 15) whose order is NH2-
young chickens 2 to 3 weeks of age. Infection causes VP2-VP4-VP3-COOH (13). The exact locations of the
destruction of lymphoid organs, especially the bursa of cleavage sites within the polyprotein are not known. It
Fabricius (1, 2). Two distinct serotypes (1 and 2) are has been considered that the VP2 and VP3 are major
recognized for IBDV. The serotype 1 virus strains differ structural proteins of the viral particle, and the VP4 is
markedly in virulence (3), whereas serotype 2 viruses a proteolytic enzyme-like protein which is involved in
are naturally avirulent for chickens (4). Until 1987, most the processing of the precursor polypeptide (16). The
of the IBDV infections were subclinical, causing im- short ORF could encode a VP5 (21 kDa), but the function
paired growth and acquired immunodeficiency (classi- of this has not been defined (17, 18). Another genome
cal IBD). Since 1987, an increasing number of acute segment B (2.7 Kb) encodes VP1 (90 kDa) which is
cases of IBD with high mortality, not only in 2- to 3- known as a putative viral RNA polymerase (19).
week-old chickens but in older birds, has been reported Strains of IBDV show reduced virulence during pas-
(highly virulent, HV-IBD) (5 – 9). sage in embryonated eggs and chicken embryo fibro-
IBDV is a member of the genus avibirnavirus in the blast (CEF) cells (20, 21). Most strains of wild-type IBDV
family Birnaviridae (10, 11). The viruses of this family recovered from infected bursa do not replicate in CEF
are characterized by a genome consisting of two seg- cells. With successive passage, however, the virus be-
ments (A and B) of double-stranded RNA and by nonen- comes progressively adapted to growth in vitro. Passage
veloped icosadhedral virus particles of about 60 nm in of the virus in vitro has been associated with attenuation
diameter (12). The nucleotide sequence of IBDV shows of virulence as evidenced by a reduction in the ability
that the segment A (3.4 kb) has a long open reading of the virus to induce bursal lesions. Extended in vitro
frame (ORF) of 3,036 bp (13) and a short ORF of 435 bp passage of the virus has been proposed as an approach
which overlaps with the 5* end of the long ORF (14). to the development of attenuated live vaccines. Recently,
The long ORF encodes a 110-kDa polyprotein which is the HV-IBD virus (HV-IBDV) strains were adapted to serial
passage in embryonated eggs and CEF cells. The CEF
cell culture-adapted strains showed considerable reduc-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /81-58-293-2947. E-mail: yamaguti@cc.gifu-u.ac.jp. tion in virulence (22). However, genetic changes respon-
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sible for IBDV attenuation have not yet been defined at reactions. The nucleotide sequences and the deduced
amino acid sequences were analyzed by the GENETYXthe molecular level.
In this study we investigated the molecular basis for analyzing system (Software Development Co., Ltd.).
The nucleotide sequence data reported in this papervirulence of HV-IBDV and attenuation by determining the
nucleotide sequences coding for precursor polyprotein will appear in the GSDB, DDBJ, EMBL, and NCBI nucleo-
tide sequence data bases with the following accessionof the attenuated strains derived from HV-IBDV and com-
paring the deduced amino acid sequences with the se- numbers: D49706 for OKYM, D83985 for OKYMT, D84072
for TKSM, D84071 for TKSMT, D16630 for DV86, D16828quences of the highly virulent parental strain. By compar-
ing genome sequences of the highly virulent parental for GBF-1, D16677 for J1, and D16678 for K.
The precursor polyprotein gene of the OKYMT strainstrains and their culture derivatives, it may be possible
to determine molecular markers of virulence. consisted of 3036 nucleotides, and 1012 amino acid resi-
dues were deduced from the nucleotide sequence.Highly virulent isolates of IBDV, OKYM, and TKSM
strains (22) were isolated in our laboratory from field Comparison of the nucleotide and deduced amino acid
sequences of the highly virulent OKYM strain with theoutbreaks of layer chickens in Okayama and Tokushima
prefectures of western Japan in 1991. The CEF cell cul- attenuated OKYMT strain revealed seven nucleotide se-
quence differences predicting five amino acid substitu-ture-adapted OKYM and TKSM strains designated
OKYMT and TKSMT, were the derivative attenuated tions in the polyprotein (Fig. 1). Five mutations from T,
G, G, C, and G in OKYM to C, A, A, T, and A in OKYMTstrains. The attenuated OKYMT was obtained after 20
passages of the highly virulent parent virus OKYM in at nucleotide position 767, 835, 850, 944, and 2413 re-
sulted in the substitution of Ile, Asp, Ala, Ser, and Ala inchorioallantoic membrane, 15 passages in yolk sac, fol-
lowed by 8 passages in CEF cells (22). The attenuated OKYM for Thr, Asn, Thr, Phe, and Thr in OKYMT at residue
256, 279, 284, 315, and 805, respectively. A NaeI site atTKSMT was obtained after 15 passage of the highly viru-
lent parent virus TKSM in chorioallantoic membrane, 21 nucleotide position 981 to 986 (GCCGGC) in the highly
virulent OKYM strain was lost in the tissue culture-passages in yolk sac, followed by 6 passages in CEF
cells (22). adapted avirulent OKYMT strain because of the nucleo-
tide substitution at position 981 (G r A). Of the five aminoA highly virulent DV86 strain (6) and a classical virulent
GBF-1 strain (23) maintained in our laboratory using spe- acid substitutions, four were predicted in the VP2 vari-
able domain and another was predicted in VP3. Twocific pathogen-free (SPF) chickens were used. The DV86
strain isolated in the Netherlands was kindly provided nucleotide substitutions from the wild-type sequence
present in the putative VP3 and VP4 coding region (posi-by Dr. P. J. Wyeth (Ministry of Agriculture, Fisheries and
Food, Central Veterinary Laboratory, New Haw, Wei- tion 2001 and 3027) did not predict a change in the amino
acid sequence of the protein. No amino acid substitu-bridge, UK) as a lyophilized infected bursa. Classical cell
culture-adapted J1 (24) and K (25) strains were also used. tions were predicted in the putative protease, VP4, or at
the proposed cleavage sites for the polyprotein pro-The highly virulent and the classical virulent strains
were propagated in 4-week-old SPF chickens, and the cessing.
Nucleotide sequences of the attenuated IBDV TKSMTcell culture-adapted strains were propagated in CEF cell
cultures. Four days postinoculation, the virus-infected strain and the parental highly virulent TKSM strain were
also determined in regard to VP2 variable domain (28),bursas and the supernatants of cell culture medium were
harvested. The viral genomic RNA was prepared from where the four amino acid substitutions were predicted
in OKYMT. Comparison of the nucleotide and deducedharvested virus by the guanidinium isothiocyanate
method (26). amino acid sequences of the virulent TKSM strain with
the attenuated TKSMT strain revealed six nucleotide se-The genomic RNA segment A of the OKYMT strain
was copied into cDNA, amplified by polymerase chain quence differences predicting five amino acid substitu-
tions in the variable domain. Five mutations from A, G,reaction (PCR), and cloned into the SmaI site of the
pUC19 plasmid as three overlapping cDNAs represent- T, G, and G in TKSM to T, A, C, A, and A in TKSMT at
nucleotide position 890, 904, 946, 966, and 981 resulteding the entire reading frame of precursor polyprotein.
The recombinant pUC19 plasmid containing the PCR- in the substitution for Gln, Gly, Ile, Asp, and Ala in TKSM
by His, Asp, Thr, Asn, and Thr in TKSMT at residues 253,amplified cDNA was sequenced using the dideoxy-
nucleotide chain termination sequencing reaction (27) 258, 272, 279, and 284, respectively. Another nucleotide
substitution at position 1079 (G r A) did not predict anand the Sequenase Version 2.0 kit (U. S. Biochemical).
The forward universal and the M13/pUC reverse (Takara amino acid substitution. A NaeI site at nucleotide posi-
tion 981 to 986 in the highly virulent TKSM strain wasShuzo Co, Ltd.) primers were used for the sequencing
reaction to obtain the nucleotide sequence in both direc- lost in the tissue culture-adapted avirulent TKSMT strain
because of the nucleotide substitution at position 981tions. To determine the correct sequence of amplified
cDNA, at least three different clones originating from the (G r A). A summary of the nucleotide and amino acid
differences of the variable domain between the attenu-same amplified reaction were used for the sequencing
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FIG. 1. Diagramatic representation of nucleotide and predicted amino acid sequence differences of the precursor polyprotein between highly
virulent OKYM and the attenuated OKYMT strains of IBDV. The stippled area indicates the position of the variable domain (28). The numbers with
and without parentheses indicate amino acid and nucleotide positions, respectively, using numbering from the sequence of segment A from Bayliss
et al. (28). The positions of VP2, VP4, and VP3 are deduced from the possible cleavage sites reported by Hudson et al. (13).
ated viruses and the parental viruses are presented in Amino acid residues Gln, Asp, and Ala at positions 253,
279, and 284 were conserved in most of strains of highTable 1.
The OKYMT and TKSMT sequences share a common pathogenicity, and His, Asn, and Thr at positions 253,
279, and 284 were conserved in most of CEF cell-adaptedmutation at base position 835 (G r A) and 850 (G r A).
These nucleotide substitutions resulted in the substitu- strains of low pathogenicity. Especially the amino acid
residue Ala and Thr at position 284 was completely con-tion of Asp and Ala in the parental highly virulent viruses
for Asn and Thr in the attenuated strains at residues 279 served in the virulent and avirulent strains, respectively.
Amino acid residues at positions 253, 279, and 284 ofand 284. The two amino acid substitutions commonly
found in the attenuated strains at residues 279 and 284 each strain are summarized in Table 2.
Attenuation of a virus by serial passage in cell culturechanged the polarity from nonpolar to polar residues. A
reduction of hydrophilia of this region and deletion of the presumably results in selection of variants better
adapted for replication in cell culture. Such an alterationa-helix which could alter the conformation of the virion
surface structures was predicted. could lead to less efficient binding to cell receptors and
penetration or to reduced adaptation for replication inThe amino acid sequences of the VP2 variable domain
of the OKYM, OKYMT, TKSM, and TKSMT strains were the natural hosts and consequently to an alteration in
tissue tropism and reduction in virulence.compared with those of highly virulent strain DV86, clas-
sical virulent strains 52/70 (Accession No. D00869) (28), All the amino acid substitutions predicted in VP2 were
located in amino acid variable domain known as theGBF-1, STC (Accession No. D00499) (14) and I (29), anti-
genic variant strain variant A (Accession No. M64285) minimum region required for reaction with virus-neu-
tralizing monoclonal antibodies (31). Of the four amino(30), and avirulent strains Cu-1 (Accession No. D00867),
PBG98 (Accession No. D00868) (28), IQ (29), K, and J1. acid substitutions, those at positions 279 (Asp r Asn)
TABLE 1
Sequence Differences of the VP2 Variable Domain between the Highly Virulent Wild-type Viruses
(OKYM and TKSM) and the Attenuated OKYMT and TKSMT Strains
Nucleotide Amino acid
Positiona WT OKYMT TKSMT Position WT OKYMT TKSMT
890 A A T 253 Gln Gln His
898 T C T 256 Ile Thr Ile
904 G G A 258 Gly Gly Asp
946 T T C 272 Ile Ile Thr
966b G A A 279 Asp Asn Asn
981 G A A 284 Ala Thr Thr
1,075 C T C 315 Ser Phe Ser
1,079 G G A 316 Gly Gly Gly
Note. WT are wild-type OKYM and TKSM strains.
a Position numbers in the nucleotide and amino acid sequences correspond to the positions reported by Bayliss et al. (28).
b Mutations commonly found in the OKYMT and TKSMT sequences are shown in boldface.
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TABLE 2
Sequence Comparison of Amino Acid Residues at Positions 253, 279, and 284 of Virulent and Attenuated Strains of IBDV
Amino acid position
Strain Propagation in CEFa Virulenceb 253 279 284
OKYM 0 // Gln Asp Ala
TKSM 0 // Gln Asp Ala
52/70 0 / Gln Asp Ala
STC 0 / Gln Asp Ala
I 0 / Gln Asn Ala
GBF-1 0 / Gln Asn Ala
Variant-A 0 / Gln Asn Ala
OKYMT / 0 Gln Asn Thr
TKSMT / 0 His Asn Thr
Cu-1 / 0 His Asn Thr
PBG98 / 0 His Asn Thr
K / 0 His Asn Thr
IQ / 0 His Asn Thr
a 0, propagation negative; /, propagation positive.
b 0, avirulent; /, virulent; //, highly virulent.
and 284 (Ala r Thr) were commonly found in the attenu- had been reported (34) at positions 222 (Ala), 256 (Ile),
and 294 (Ile) which differ from classical strains. Theseated strains. It was supposed that the two amino acid
residues were important for virulence of IBDV. Biological amino acid residues were also found in both the tissue
culture adapted strains derived from highly virulentfunction of the amino acid residues has not yet been
defined. However, capsid protein determines virus bio- strains. In addition, serine-rich heptapeptide, Ser-Trp-
Ser-Ala-Ser-Gly-Ser, which was reported as an aminological functions such as tissue tropism and infection.
Because these amino acid substitutions were responsi- acid motif conserved in the virulent strain (35) was com-
pletely conserved in the attenuated strains. The aminoble for attenuation by repeated passage in cell culture,
it was speculated that the amino acid residues may play acid residues at positions 279 (Asp) and 284 (Ala) re-
ported in this study may be another important amino acidan important role for virulence of IBDV as the receptor-
binding site which determines tissue tropism. for virulence. Mutation at any position in the sequence
may lead to biological changes and alter the virulenceThe amino acid residue Gln and His at position 253
were conserved in most of virulent and attenuated in chickens.
Nucleotide sequence analysis revealed that a restric-strains, respectively (Table 2). In case of attenuated
OKYMT strain, Gln was predicted at position 253. How- tion endonuclease NaeI recognizing sequence at nucleo-
tide position 981 to 986 (GCCGGC) in highly virulentever, an amino acid substitution at position 256 (Ile r
Thr) adjacent to the position 253 was predicted. The con- OKYM and TKSM strains was lost in the tissue culture
adapted avirulent OKYMT and TKSMT strains becauseformational structure of this region rather than amino
acid residue at position 253 may also be important for of the nucleotide substitution at position 981 (G r A).
This nucleotide substitution predicted amino acid substi-tissue tropism.
An amino acid substitution was predicted at position tution at position 284 (Ala r Thr) mentioned above. This
NaeI site may be a useful restriction marker to differenti-805 (Ala r Thr) in putative VP3 of the attenuated strain.
Previous reports showed that an anti-VP3 virus neutraliz- ate a highly virulent strain from attenuated (tissue culture
adapted) strains.ing monoclonal antibody inhibited the virus attachment
to the susceptible cells (32, 33). Although the recognition In the present study, it was suggested that the amino
acid residues at positions 279 and 284 was importantsite of the monoclonal antibody was not defined, the
amino acid residue at position 805 could play an im- for virulence or propagation in CEF cells. The mutations
we identified in the OKYMT variant provide informationportant role in receptor-mediated virus–cell attachment.
The absence of mutations in the putative protease, VP4, that will be useful in understanding the molecular basis
of virulence or adaptation of IBDV to cell culture. How-or at proposed cleavage sites for polyprotein processing
in IBDV, suggests that changes in posttranslational pro- ever, from these studies we were unable to identify the
precise mutations involved in attenuation of the wild-typecessing do not play major roles in attenuation and adap-
tation of virus to cell culture. OKYM strain. Functional changes resulting from changes
in amino acids within individual proteins can only beHighly virulent strains specific 3 amino acid residues
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